Actively Recruiting
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
Led by Epiminder America, Inc. · Updated on 2026-05-06
210
Participants Needed
11
Research Sites
135 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This research is being done to understand how the Minder System helps physicians make decisions about participant's epilepsy treatment after an actionable event. The Minder System was granted De Novo classification by the U.S. Food and Drug Administration (FDA) and is not investigational. Participants that have completed the DETECT study and received the Minder System previously will consent to join this long-term follow-up observational study. The study will collect information about general wellbeing, use of healthcare services, and experience using the Minder data over time to support long-term epilepsy care. All participants will continue to be followed by their treating physician and undergo assessments and visits every six (6) months until two (2) years after receiving the Minder device.
CONDITIONS
Official Title
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant met all inclusion criteria, was enrolled in the DETECT study, and received the Minder device
- Participant completed the DETECT study by receiving an actionable event or by completing the 6-month follow-up visit
- Participant continues to have the Minder device implanted
- Participant must continue to meet relevant DETECT study inclusion criteria
You will not qualify if you...
- Participant meets any relevant DETECT study exclusion criteria including needing treatments or assessments that are not indicated with the Minder System like Magnetic Resonance Imaging (MRI)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
Mayo Clinic - Arizona
Phoenix, Arizona, United States, 85054
Actively Recruiting
2
Stanford
Palo Alto, California, United States, 94304
Actively Recruiting
3
Yale School of Medicine
New Haven, Connecticut, United States, 06510
Actively Recruiting
4
Mayo Clinic - Florida
Jacksonville, Florida, United States, 32224
Actively Recruiting
5
USF Health
Tampa, Florida, United States, 33606
Actively Recruiting
6
IU Health Neuroscience Center
Indianapolis, Indiana, United States, 46202
Enrolling by Invitation
7
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Actively Recruiting
8
Mayo Clinic - Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
9
Washington University
St Louis, Missouri, United States, 63130
Actively Recruiting
10
Atrium Health Neurosciences Institute - Charlotte
Charlotte, North Carolina, United States, 28204
Actively Recruiting
11
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
E
Epiminder, Director of Clinical Trials
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here